# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Squamous cell carcinoma

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 645 results.
Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell Carcinoma
Status: Recruiting
Last Changed: Jun 14, 2019
First Received: Sep 11, 2017
Disease(s): Esophageal Squamous Cell Carcinoma
Intervention(s): Nivolimumab+Carboplatin/paclitaxel+Radiation
Locations: University of Califonia, San Diego, La Jolla, California, United States
University of Southern California, Los Angeles, California, United States
New York University School of Medicine, New York, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Oregon Health Sciences University, Portland, Oregon, United States
... and 1 other locations.
A Study of Triprizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.
Status: Recruiting
Last Changed: Sep 10, 2019
First Received: Sep 10, 2019
Disease(s): Esophageal Squamous Cell Carcinoma
Intervention(s): Triprizumab, Paclitaxel, Albumin-Bound, Radiotherapy, Platinum-Based Drug
Locations: Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Moderately Hypofractionated Conformal Radiation Combined With Cisplatin for Esophageal Squamous Cell Carcinoma
Status: Recruiting
Last Changed: Sep 10, 2018
First Received: Sep 06, 2018
Disease(s): Esophageal Squamous Cell Carcinoma
Intervention(s): Moderately hypofractionated conformal radiation combined With cisplatin
Locations: Hui Liu, Guangzhou, Guangdong, China
Metformin in Combined With Cisplatin Plus Paclitaxel With Advanced Esophageal Squamous Cell Carcinoma (ECMTPneo)
Status: Not yet recruiting
Last Changed: Feb 15, 2019
First Received: Feb 07, 2019
Disease(s): Esophageal Squamous Cell Carcinoma
Intervention(s): metformin and chemotherapy
Locations: Peking Universtiy Cancer Hospital, Beijing, Beijing, China
Combination of Pembrolizumab With Chemoradiation for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
Status: Recruiting
Last Changed: Feb 15, 2019
First Received: Jan 03, 2019
Disease(s): Esophageal Squamous Cell Carcinoma
Intervention(s): Pembrolizumab
Locations: Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, Shanghai, China
Nal-iri/lv5-fu Versus Paclitaxel as Second Line Therapy in Patients With Metastatic Oesophageal Squamous Cell Carcinoma
Status: Recruiting
Last Changed: Mar 14, 2019
First Received: Oct 25, 2018
Disease(s): Squamous Cell Carcinoma
Intervention(s): Onivyde, Paclitaxel
Locations: Ch Perpignan, Perpignan, France
Chu de Poitiers, Poitiers, France
Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Status: Recruiting
Last Changed: Apr 11, 2019
First Received: Nov 16, 2016
Disease(s): Esophageal Squamous Cell Carcinoma
Intervention(s): Docetaxel, Nedaplatin, chest radiation
Locations: Hui Liu, Guangzhou, Guangdong, China
Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study
Status: Recruiting
Last Changed: Apr 19, 2019
First Received: Feb 10, 2016
Disease(s): Head and Neck Squamous Cell Carcinoma
Intervention(s): 18-F FDG
Locations: University Health Network, Princess Margaret Cancer Center, Toronto, Ontario, Canada
KN046 in Subjects With Late Stage Esophageal Squamous Cell Carcinoma
Status: Recruiting
Last Changed: Jun 24, 2019
First Received: Apr 24, 2019
Disease(s): Esophageal Squamous Cell Carcinoma
Intervention(s): KN046
Locations: 307 Hospital of PLA, Beijing, Beijing, China
KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
Status: Recruiting
Last Changed: May 29, 2019
First Received: Apr 25, 2019
Disease(s): Esophageal Squamous Cell Carcinoma
Intervention(s): KN046, palliative radiotherapy, KN046
Locations: The First Affiliated Hospital of Suzhou University, Suzhou, China